Expanded Access - Compassionate Use

Autolus is fully committed to the development of safe and effective therapies for patients and places a strong emphasis on prioritizing patient needs.

Expanded access, which is also referred to as compassionate use, offers a potential avenue for patients with immediately life-threatening conditions or serious diseases to obtain an investigational drug or other medical product for treatment outside of clinical trials when there are no comparable or satisfactory alternative treatment options available.

Our primary objective is to swiftly provide a novel category of CAR-T therapies to patients through efficient drug development processes and enhanced patient accessibility.

At present, Autolus does not have any ongoing Expanded Access protocols, and we do not offer access to our investigational products through Expanded Access.

If you are a health care provider who is interested in learning more about one of our investigational therapies, or a physician with questions about participation in one of our clinical trials, please submit a request to [email protected].